602 related articles for article (PubMed ID: 15556624)
61. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
Parks SK; Cormerais Y; Durivault J; Pouyssegur J
Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
[TBL] [Abstract][Full Text] [Related]
62. Cancer-associated carbonic anhydrases and their inhibition.
Pastorekova S; Zatovicova M; Pastorek J
Curr Pharm Des; 2008; 14(7):685-98. PubMed ID: 18336315
[TBL] [Abstract][Full Text] [Related]
63. Optimization of a novel peptide ligand targeting human carbonic anhydrase IX.
Rana S; Nissen F; Marr A; Markert A; Altmann A; Mier W; Debus J; Haberkorn U; Askoxylakis V
PLoS One; 2012; 7(5):e38279. PubMed ID: 22693612
[TBL] [Abstract][Full Text] [Related]
64. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.
Måseide K; Kandel RA; Bell RS; Catton CN; O'Sullivan B; Wunder JS; Pintilie M; Hedley D; Hill RP
Clin Cancer Res; 2004 Jul; 10(13):4464-71. PubMed ID: 15240538
[TBL] [Abstract][Full Text] [Related]
65. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
[TBL] [Abstract][Full Text] [Related]
66. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
[TBL] [Abstract][Full Text] [Related]
67. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
Potter CP; Harris AL
Br J Cancer; 2003 Jul; 89(1):2-7. PubMed ID: 12838292
[TBL] [Abstract][Full Text] [Related]
68. Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
Jaiswal M; Khadikar PV; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Jun; 14(12):3283-90. PubMed ID: 15149691
[TBL] [Abstract][Full Text] [Related]
69. Carbonic anhydrase IX in malignant pleural mesotheliomas: a potential target for anti-cancer therapy.
Kivelä AJ; Knuuttila A; Räsänen J; Sihvo E; Salmenkivi K; Saarnio J; Pastorekova S; Pastorek J; Waheed A; Sly WS; Salo JA; Parkkila S
Bioorg Med Chem; 2013 Mar; 21(6):1483-8. PubMed ID: 23036334
[TBL] [Abstract][Full Text] [Related]
70. In vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia.
Bao B; Groves K; Zhang J; Handy E; Kennedy P; Cuneo G; Supuran CT; Yared W; Rajopadhye M; Peterson JD
PLoS One; 2012; 7(11):e50860. PubMed ID: 23226406
[TBL] [Abstract][Full Text] [Related]
71. Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment.
Zavadova Z; Zavada J
Oncol Rep; 2005 May; 13(5):977-82. PubMed ID: 15809767
[TBL] [Abstract][Full Text] [Related]
72. Regulation of tumor pH and the role of carbonic anhydrase 9.
Swietach P; Vaughan-Jones RD; Harris AL
Cancer Metastasis Rev; 2007 Jun; 26(2):299-310. PubMed ID: 17415526
[TBL] [Abstract][Full Text] [Related]
73. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
74. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas.
Hedley D; Pintilie M; Woo J; Morrison A; Birle D; Fyles A; Milosevic M; Hill R
Clin Cancer Res; 2003 Nov; 9(15):5666-74. PubMed ID: 14654550
[TBL] [Abstract][Full Text] [Related]
75. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
[TBL] [Abstract][Full Text] [Related]
76. Hypoxia-inducible carbonic anhydrase IX expression is insufficient to alleviate intracellular metabolic acidosis in the muscle of zebrafish, Danio rerio.
Esbaugh AJ; Perry SF; Gilmour KM
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R150-60. PubMed ID: 18945954
[TBL] [Abstract][Full Text] [Related]
77. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
[TBL] [Abstract][Full Text] [Related]
78. Carbonic anhydrase IX expression in prostate cancer.
Smyth LG; O'Hurley G; O'Grady A; Fitzpatrick JM; Kay E; Watson RW
Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):178-81. PubMed ID: 20038959
[TBL] [Abstract][Full Text] [Related]
79. Ectodomain shedding of the hypoxia-induced carbonic anhydrase IX is a metalloprotease-dependent process regulated by TACE/ADAM17.
Zatovicova M; Sedlakova O; Svastova E; Ohradanova A; Ciampor F; Arribas J; Pastorek J; Pastorekova S
Br J Cancer; 2005 Nov; 93(11):1267-76. PubMed ID: 16278664
[TBL] [Abstract][Full Text] [Related]
80. Fluorescence- and spin-labeled carbonic anhydrase inhibitors.
Cecchi A; Supuran CT
Curr Pharm Des; 2008; 14(7):699-707. PubMed ID: 18336316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
